Company profile: Anji Pharma
1.1 - Company Overview
Company description
- Provider of therapeutics targeting high-value, human genetics-validated targets, including ANJ900, a gut-targeted formulation of metformin for type 2 diabetes patients with advanced chronic kidney disease to lower glucose with reduced systemic exposure, and ANJ908 (Pradigastat), a DGAT1 inhibitor for chronic idiopathic constipation to increase bowel movement frequency and soften stool.
Products and services
- ANJ908 (Pradigastat): A DGAT1-targeted inhibitor addressing chronic idiopathic constipation by increasing bowel movement frequency and softer stools via altering the intestinal milieu
- ANJ900: An engineered, gut-targeted metformin formulation for type 2 diabetes with advanced chronic kidney disease, lowering glucose while minimizing systemic exposure
- Genetics-validated target strategy: A genetics-validated research emphasis on tackling high-value targets confirmed by human genetics
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Anji Pharma
EdenRoc Sciences
HQ: United States
Website
- Description: Provider of holding and operating services for bioscience and pharmaceutical startups, managing Metro International Biotech (proprietary NAD boosters), Cantata Bio (NGS-based multiomics tools via Dovetail Genomics and Arc Bio), Claret Bioscience, Astrea Forensics (advanced DNA for casework), Delavie Sciences (consumer care ingredients), and Liberty Biosecurity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EdenRoc Sciences company profile →
Cumberland Pharmaceuticals
HQ: United States
Website
- Description: Provider of specialty pharmaceutical offerings focused on acquiring, developing, and commercializing branded prescription products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cumberland Pharmaceuticals company profile →
Meda Pharma
HQ: United States
Website
- Description: Provider of pharmaceutical products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Meda Pharma company profile →
Stada
HQ: Germany
Website
- Description: Provider of pharmaceuticals and non-prescription consumer health products, operating on three pillars: OTC consumer healthcare, generics, and specialty pharmaceuticals. Sells products in over 120 countries, including acetaminophen, lactulose, Grippostad-C, Vitaprost, Cardiomagnyl, Xefocam Rapid, Aqualor, Edarbi, and Levomekol.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stada company profile →
Pharmion
HQ: United States
Website
- Description: Provider of products for the treatment of hematology and oncology patients, focused on acquisition, development, and commercialization. Global biotech partnering with scientific and clinical advisors to identify and develop products for hematology and oncology markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharmion company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Anji Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Anji Pharma
2.2 - Growth funds investing in similar companies to Anji Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Anji Pharma
4.2 - Public trading comparable groups for Anji Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →